Interplay between positive and negative elongation factors: Drawing a new view of DRB

Genes to Cells

Volumn 3, Issue 1, 1998, Pages 9-15

  Yamaguchi, Yuki ^a   Wada, Tadashi ^a   Handa, Hiroshi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN;

GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

DICHLORORIBOFURANOSYLBENZIMIDAZOLE; ENZYME INHIBITORS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; GENES, TAT; HIV; HUMANS; NUCLEAR PROTEINS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN-SERINE-THREONINE KINASES; RNA POLYMERASE II; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031878799     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.1998.00162.x     Document Type: Review

References (59)

1. Bjorklund, S. & Kim, Y.-J. (1996) Mediator of transcriptional regulation. Trends Biochem. Sci. 21, 335-337.
2. Bortvin, A. & Winston, F. (1996) Evidence that Spt6p controls chromatin structure by a direct interaction with histones. Science 272, 1473-1476.
3. Brown, S.A., Imbalzano, A.N. & Kingston, R.E. (1996) Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev. 10, 1479-1490.
4. Buermeyer, A.B., Thompson, N.E., Strasheim, L.A., Burgess, R.R. & Farnham, P.J. (1992) The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II. Mol. Cell. Biol. 12, 2250-2259.
5. Buratowski, S. & Sharp, P.A. (1990) Transcription initiation complexes and upstream activation with RNA polymerase II lacking the C-terminal domain of the largest subunit. Mol. Cell. Biol. 10, 5562-5564.
6. Chang, C.-H. & Luse, D.S. (1997) The H3/H4 tetramer blocks transcript elongation by RNA polymerase II in vitro. J. Biol. Chem. 272, 23427-23434.
7. Chiang, P.W., Fogel, E., Jackson, C.L., et al. (1996) Isolation, sequencing, and mapping of the human homologue of the yeast transcription factor, SPT5. Genomics 38, 421-424.
8. Chodosh, L.A., Fire, A., Samuels, M. & Sharp, P.A. (1989) 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264, 2250-2257.
9. Chun, R.F. & Jeang, K.T. (1996) Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271, 27888-27894.
10. Critchfield, J.W., Coligan, J.E., Folks, T.M. & Butera, S.T. (1997) Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proc. Natl. Acad. Sci. USA 94, 6110-6115.
11. Dahmus, M.E. (1996) Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271, 19009-19012.
12. Egyhazi, E., Ossoinak, A., Pigon, A., Holmgren, C., Lee, J.M. & Greenleaf, A.L. (1996) Phosphorylation dependence of the initiation of productive transcription of Balbiani ring 2 genes in living cells. Chromosoma 104, 422-433.
13. Eisenmann, D.M., Dollard, C. & Winston, F. (1989) SPT15, the gene encoding the yeast TATA binding factor TFIID, is required for normal transcription initiation in vivo. Cell 58, 1183-1191.
14. Fraser, N.W., Sehgal, P.B. & Darnell, J.E. (1978) DRB-induced premature termination of late adenovirus transcription. Nature 272, 590-593.
15. Gerber, H.P., Hagmann, M., Seipel, K., et al. (1995) RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature 374, 660-662.
16. Grana, X., De Luca, A., Sang, N., et al. (1994) PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA 91, 3834-3838.
17. Greenblatt, J., Nodwell, J.R. & Mason, S.W. (1993) Transcriptional antitermination. Nature 364, 401-406.
18. Hahn, S., Buratowski, S., Sharp, P.A. & Guarente, L. (1989) Isolation of the gene encoding the yeast TATA binding protein TFIID: a gene identical to the SPT15 suppressor of Ty element insertions. Cell 58, 1173-1181.
19. Hartzog, G.A., Basrai, M.A., Ricupero-Hovasse, S.L., Hieter, P. & Winston, F. (1996) Identification and analysis of a functional human homolog of the SPT4 gene of Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 2848-2856.
20. Hartzog, G.A., Wada, T., Handa, H. & Winston, F. (1998) Evidence that Spt4, Spt5, and Spt6 control. transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12, 357-369.
21. Izban, M.G. & Luse, D.S. (1991) Transcription on nucleosomal templates by RNA polymerase II in vitro: inhibition of elongation with enhancement of sequence-specific pausing. Genes Dev. 5, 683-696.
22. Jones, K.A. (1993) Tat and the HIV-1 promoter. Curr. Opin. Cell. Biol. 5, 461-468.
23. Kyrpides, N.C., Woese, C.R. & Ouzounis, C.A. (1996) KOW: a novel motif linking a bacterial transcription factor with ribosomal proteins. Trends Biochem. Sci. 21, 425-426.
24. Li, Y. & Kornberg, R.D. (1994) Interplay of positive and negative effectors in function of the C-terminal repeat domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA 91, 2362-2366.
25. Li, J., Mason, S.W. & Greenblatt, J. (1993) Elongation factor NusG interacts with termination factor p to regulate termination and antitermination of transcription. Genes Dev. 7, 161-172.
26. Malone, E.A., Fassler, J.S. & Winston, F. (1993) Molecular and genetic characterization of SPT4, a gene important for transcription initiation in Saccharomyces cerevisiae. Mol. Gen. Genet. 237, 449-459.
27. Mancebo, H.S.Y., Lee, G., Flygare, J., et al. (1997) P-TEFb kinase is required for HIV tat transcriptional activation in vivo and in vitro. Genes Dev. 11, 2633-2644.
28. Marciniak, R.A. & Sharp, P.A. (1991) HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10, 4189-4196.
29. Marshall, N.F., Peng, J., Xie, Z. & Price, D.H. (1996) Control. of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271, 27176-27183.
30. Marshall, N.F. & Price, D.H. (1992) Control. of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12, 2078-2090.
31. Marshall, N.F. & Price, D.H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270, 12335-12338.
32. Mogridge, J., Mah, T.F. & Greenblatt, J. (1995) A protein-RNA interaction network facilitates the template-independent cooperative assembly on RNA polymerase of a stable antitermination complex containing the λN protein. Genes Dev. 9, 2831-2845.
33. Okamoto, H., Sheline, C., Cordon, J., Jones, K. & Peterlin, B. (1996) Trans-activation by human immunodeficiency virus type 1 and 2 Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA 93, 11575-11579.
34. Peterson, C.L., Kruger, W. & Herskowitz, I. (1991) A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1. Cell 64, 1135-1143.
35. Reines, D., Conaway, J.W. & Conaway, R.C. (1996) The RNA polymerase II general elongation factors. Trends Biochem. Sci. 21, 351-355.
36. Roeder, R.G. (1976) Eukaryotic nuclear RNA polymerases. In: RNA polymerase (eds R. Losick & M. Chamberlin), pp. 285-329. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
37. Scafe, C., Chao, D., Lopes, J., Hirsch, J.P., Henry, S. & Young, R.A. (1990) RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals. Nature 347, 491-494.
38. Sehgal, P.B., Darnell, J.E. & Tamm, I. (1976) The inhibition by DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells. Cell 9, 473-480.
39. Serizawa, H., Conaway, J.W. & Conaway, R.C. (1993) Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature 363, 371-374.
40. Stachora, A.A., Schafer, R.E., Pohlmeier, M., Maier, G. & Ponstingl, H. (1997) Human Supt5h protein, a putative modulator of chromatin structure, is reversibly phosphorylated in mitosis. FEBS Lett. 409, 74-78.
41. Steinmetz, E.J. (1997) Pre-mRNA processing and the CTD of RNA polymerase II: The tail that wags the dog? Cell 89, 491-494.
42. Stirpe, F. & Fiume, L. (1967) Effect of α-amanitin on ribonucleic acid synthesis and on ribonucleic acid polymerase in mouse liver. Biochem. J. 103, 67-68.
43. Swanson, M.S., Malone, E.A. & Winston, F. (1991) SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol. Cell. Biol. 11, 3009-3019.
44. Swanson, M.S. & Winston, F. (1992) SPT4, SPT5 and SPT6 interactions: effects on transcription and viability in Saccharomyces cerevisiae. Genetics 132, 325-336.
45. Tamm, I. & Kikuchi, T. (1979) Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-β-D-ribofuranosylbenzimidazole. Proc. Natl. Acad. Sci. USA 76, 5750-5754.
46. Tamm, I., Nemes, M.M. & Osterhout, S. (1960) On the role of ribonucleic acid in animal virus synthesis. I. Studies with 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole. J. Exp. Med. 111, 339-349.
47. Tamm, I. & Tyrrell, D.A.J. (1954) Influenza virus multiplication in the chorioallantoic membrane in vitro: kinetic aspects of inhibition by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole. J. Exp. Med. 100, 541-562.
48. Uptain, S.M., Kane, C.M. & Chamberlin, M.J. (1997) Basic mechanisms of transcript elongation and its regulation. Annu. Rev. Biochem. 66, 117-172.
49. Usheva, A., Maldonado, E., Goldring, A., et al. (1992) Specific interaction between the nonphosphorylated form of RNA polymerase II and the TATA-binding protein. Cell 69, 871-881.
50. Wada, T., Takagi, T., Yamaguchi, Y., et al. (1998) DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343-356.
51. Winston, F. (1992) Analysis of SPT genes: A genetic approach toward analysis of TFIID, histones, and other transcription factors of yeast. In Transcriptional regulation (eds S.L. McKinght & K.R. Yamamoto), pp. 1271-1293. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
52. Winston, F. & Carlson, M. (1992) Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8, 387-391.
53. Wu-Baer, F., Sigman, D. & Gaynor, R.B. (1995) Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA 92, 7153-7157.
54. Yang, X., Herrmann, C.H. & Rice, A.P. (1996) The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70, 4576-4584.
55. Yankulov, K.Y., Pandes, M., McCracken, S., Bouchard, D. & Bentley, D.L. (1996) TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes. Mol. Cell. Biol. 16, 3291-3299.
56. Yankulov, K., Yamashita, K., Roy, R., Egly, J.M. & Bentley, D.L. (1995) The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270, 23922-23925.
57. Zandomeni, R., Mittleman, B., Bunick, D., Ackerman, S. & Weinmann, R. (1982) Mechanism of action of dichloro-β-D-ribofuranosylbenzimidazole: effect on in vitro transcription. Proc. Natl. Acad. Sci. USA 79, 3167-3170.
58. Zandomeni, R., Zandomeni, M.C., Shugar, D. & Weinmann, R. (1986) Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J. Biol. Chem. 261, 3414-3419.
59. Zhu, Y., Pe'ery, T., Peng, J., et al. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11, 2622-2632.